» Articles » PMID: 12436455

Power and Sample Size for DNA Microarray Studies

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2002 Nov 19
PMID 12436455
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

A microarray study aims at having a high probability of declaring genes to be differentially expressed if they are truly expressed, while keeping the probability of making false declarations of expression acceptably low. Thus, in formal terms, well-designed microarray studies will have high power while controlling type I error risk. Achieving this objective is the purpose of this paper. Here, we discuss conceptual issues and present computational methods for statistical power and sample size in microarray studies, taking account of the multiple testing that is generic to these studies. The discussion encompasses choices of experimental design and replication for a study. Practical examples are used to demonstrate the methods. The examples show forcefully that replication of a microarray experiment can yield large increases in statistical power. The paper refers to cDNA arrays in the discussion and illustrations but the proposed methodology is equally applicable to expression data from oligonucleotide arrays.

Citing Articles

Computing Power and Sample Size for the False Discovery Rate in Multiple Applications.

Ni Y, Seffernick A, Onar-Thomas A, Pounds S Genes (Basel). 2024; 15(3).

PMID: 38540403 PMC: 10970028. DOI: 10.3390/genes15030344.


Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma.

Simonetti S, Iuliani M, Stellato M, Cavaliere S, Vincenzi B, Tonini G J Immunother Cancer. 2022; 10(9).

PMID: 36104102 PMC: 9476128. DOI: 10.1136/jitc-2022-005136.


Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.

Pantano F, Zalfa F, Iuliani M, Simonetti S, Manca P, Napolitano A Cancers (Basel). 2022; 14(10).

PMID: 35626040 PMC: 9139420. DOI: 10.3390/cancers14102435.


Pig Genomics and Genetics.

Piorkowska K, Ropka-Molik K Genes (Basel). 2021; 12(11).

PMID: 34828298 PMC: 8623580. DOI: 10.3390/genes12111692.


RNASeqDesign: A framework for RNA-Seq genome-wide power calculation and study design issues.

Lin C, Liao S, Liu P, Park Y, Ting Lee M, Tseng G J R Stat Soc Ser C Appl Stat. 2021; 68(3):683-704.

PMID: 33692596 PMC: 7941184. DOI: 10.1111/rssc.12330.